Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous versus nebulized dexmedetomidine for blood loss reduction during functional endoscopic sinus surgery
PACTR202601692450392Not yet recruiting
- Sponsor
- Assiut University
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of dexmedetomidine in ear (not a disease) (2 arms), sponsored by Assiut University. Primary endpoint: Total intraoperative blood loss. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
ear (not a disease)
Beyond the preview
Go deeper on PACTR202601692450392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202601692450392.